The European Medicines Agency (EMA) said Thursday that it had begun assessing whether to authorise Moderna’s Covid vaccine for children aged six months to five years old, the only group not yet eligible for the jab in most countries.
“We have just started the evaluation of an application from Moderna to extend the use of Spikevax to children from six months of age to five years,” said senior EMA official Marco Cavaleri. “This is the first application for this young age group,” he added.
